March 10, 2011
Otsuka Pharmaceutical Co., Ltd.
Otsuka Pharmaceutical Received Approval for Additional Indication of L-Cartin® tablets for Carnitine Deficiency in Japan
Tokyo, Japan, March 10, 2011 -- Otsuka Pharmaceutical Co., Ltd. today announced that it received an approval for Additional Indication of L-Cartin® tablets (nonproprietary name: levocarnitine chloride) for carnitine deficiency.
Information in this news release was current as of the original release date.